Legend Biotech (LEGN) News Today $32.11 +0.11 (+0.34%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Legend Biotech Co. (NASDAQ:LEGN) Shares Purchased by Renaissance Technologies LLCRenaissance Technologies LLC grew its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 4,917.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 908,100 shares of the company's stock after buying an additional 890,000 shares during the quarter. RenaissaApril 14 at 5:14 AM | marketbeat.comResona Asset Management Co. Ltd. Purchases New Shares in Legend Biotech Co. (NASDAQ:LEGN)Resona Asset Management Co. Ltd. acquired a new position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 17,450 shares of the company's stock, valued at apApril 13 at 4:57 AM | marketbeat.comCenterBook Partners LP Has $4.03 Million Stake in Legend Biotech Co. (NASDAQ:LEGN)CenterBook Partners LP boosted its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 63.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 123,791 shares of the company's stockApril 12 at 6:59 AM | marketbeat.comFmr LLC Sells 4,883,207 Shares of Legend Biotech Co. (NASDAQ:LEGN)Fmr LLC trimmed its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 26.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,447,012 shares of the company's stock after selliApril 12 at 5:42 AM | marketbeat.comBiotech stocks to own amid market volatility – Piper SandlerApril 11 at 3:07 PM | msn.comLegend Biotech's (LEGN) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and issued a $75.00 target price on shares of Legend Biotech in a report on Tuesday.April 10, 2025 | marketbeat.comFederated Hermes Inc. Has $48.49 Million Holdings in Legend Biotech Co. (NASDAQ:LEGN)Federated Hermes Inc. lessened its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 3.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,490,300 shares of the compaApril 10, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Shares Acquired by Prudential PLCPrudential PLC boosted its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 47.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 39,566 shares of the company's stock after purchasing an additional 12,744April 10, 2025 | marketbeat.comPolymer Capital Management HK LTD Has $935,000 Holdings in Legend Biotech Co. (NASDAQ:LEGN)Polymer Capital Management HK LTD decreased its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 31.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 28,727 shares of the company's stock after selling 13,100April 9, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Shares Bought by JPMorgan Chase & Co.JPMorgan Chase & Co. lifted its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 176.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 998,016 shares of the company's stock after buying an additional 636,390 shares during the perApril 9, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Hits New 12-Month Low - What's Next?Legend Biotech (NASDAQ:LEGN) Reaches New 1-Year Low - Should You Sell?April 9, 2025 | marketbeat.comSpringhill Fund Asset Management HK Co Ltd Invests $6.21 Million in Legend Biotech Co. (NASDAQ:LEGN)Springhill Fund Asset Management HK Co Ltd bought a new position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 190,800 shares of the company's stock, valued at apprApril 8, 2025 | marketbeat.comCritical Contrast: Legend Biotech (NASDAQ:LEGN) versus Day One Biopharmaceuticals (NASDAQ:DAWN)April 8, 2025 | americanbankingnews.comLegend Biotech Co. (NASDAQ:LEGN) Stock Position Lowered by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA trimmed its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 0.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,263,556 shares of the company's stock after sApril 7, 2025 | marketbeat.comAlliancebernstein L.P. Buys 164,418 Shares of Legend Biotech Co. (NASDAQ:LEGN)Alliancebernstein L.P. lifted its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 12.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,476,151 shares of the company's stock after acquiring an additionApril 7, 2025 | marketbeat.comWellington Management Group LLP Has $69.01 Million Position in Legend Biotech Co. (NASDAQ:LEGN)Wellington Management Group LLP grew its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 4.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,120,775 shares of the company's sApril 7, 2025 | marketbeat.comSei Investments Co. Increases Stock Holdings in Legend Biotech Co. (NASDAQ:LEGN)Sei Investments Co. increased its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 29.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 66,855 shares of the company's stock after buying an additApril 7, 2025 | marketbeat.comCinctive Capital Management LP Makes New Investment in Legend Biotech Co. (NASDAQ:LEGN)Cinctive Capital Management LP acquired a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 30,694 shares of the company's stock,April 6, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Position Increased by Headlands Technologies LLCHeadlands Technologies LLC raised its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 2,023.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,935 shares of the company's stApril 6, 2025 | marketbeat.comSchroder Investment Management Group Has $6.37 Million Holdings in Legend Biotech Co. (NASDAQ:LEGN)Schroder Investment Management Group raised its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 74.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 194,508 shares of the company's stock after purchasing anApril 6, 2025 | marketbeat.comGroupama Asset Managment Purchases 17,533 Shares of Legend Biotech Co. (NASDAQ:LEGN)Groupama Asset Managment grew its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 64.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,907 shares of the company's stock after puApril 4, 2025 | marketbeat.comKLP Kapitalforvaltning AS Buys New Holdings in Legend Biotech Co. (NASDAQ:LEGN)KLP Kapitalforvaltning AS purchased a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 18,400 shares of the company's stock, valueApril 4, 2025 | marketbeat.comWhat Does the Market Think About Legend Biotech?April 3, 2025 | benzinga.comLegend Biotech Co. (NASDAQ:LEGN) Short Interest Down 13.1% in MarchLegend Biotech Co. (NASDAQ:LEGN - Get Free Report) saw a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 11,390,000 shares, a drop of 13.1% from the February 28th total of 13,100,000 shares. Currently, 6.2% of the company's stock are sold short. Based on an average daily volume of 1,230,000 shares, the days-to-cover ratio is presently 9.3 days.April 3, 2025 | marketbeat.comKorea Investment CORP Sells 21,100 Shares of Legend Biotech Co. (NASDAQ:LEGN)Korea Investment CORP trimmed its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 49.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,490 shares of the company's stock after selling 21April 3, 2025 | marketbeat.comNEOS Investment Management LLC Sells 12,537 Shares of Legend Biotech Co. (NASDAQ:LEGN)NEOS Investment Management LLC reduced its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 52.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,362 shares of the company's stock after selling 12,537April 2, 2025 | marketbeat.comMarks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks FallApril 1, 2025 | markets.businessinsider.comArtisan Partners Limited Partnership Purchases 915,891 Shares of Legend Biotech Co. (NASDAQ:LEGN)Artisan Partners Limited Partnership lifted its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 155.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,505,562 shares of theMarch 30, 2025 | marketbeat.comEntryPoint Capital LLC Invests $248,000 in Legend Biotech Co. (NASDAQ:LEGN)EntryPoint Capital LLC bought a new stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 7,614 shares of the company's stock, valued at approximatelyMarch 30, 2025 | marketbeat.comQuantbot Technologies LP Purchases 8,500 Shares of Legend Biotech Co. (NASDAQ:LEGN)Quantbot Technologies LP raised its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 280.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,532 shares of the company'March 30, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Position Increased by IvyRock Asset Management HK LtdIvyRock Asset Management HK Ltd raised its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 3,827.9% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 267,100 shares of the company's stock after purchasing an additional 260,300 shares during tMarch 26, 2025 | marketbeat.comTaikang Asset Management Hong Kong Co Ltd Purchases 52,145 Shares of Legend Biotech Co. (NASDAQ:LEGN)Taikang Asset Management Hong Kong Co Ltd increased its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 107.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 100,475 shares of the company's stock after buying an additional 52,145 sMarch 26, 2025 | marketbeat.comFox Run Management L.L.C. Makes New $421,000 Investment in Legend Biotech Co. (NASDAQ:LEGN)Fox Run Management L.L.C. acquired a new stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 12,924 shares of the company's stock, valued at approximately $421,000. Other hedge funds also receMarch 26, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) have been given a consensus rating of "Moderate Buy" by the twelve research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and eleven have given a bMarch 25, 2025 | marketbeat.comiA Global Asset Management Inc. Buys New Stake in Legend Biotech Co. (NASDAQ:LEGN)iA Global Asset Management Inc. bought a new stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 76,380 shares of the company's sMarch 23, 2025 | marketbeat.comSector Gamma AS Has $1.58 Million Stock Position in Legend Biotech Co. (NASDAQ:LEGN)Sector Gamma AS raised its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 25.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 48,495 shares of the company's stock after acquiring an additional 9,733 shares during the quarter. SectMarch 22, 2025 | marketbeat.comDemystifying Legend Biotech: Insights From 5 Analyst ReviewsMarch 19, 2025 | benzinga.comSkandinaviska Enskilda Banken AB publ Sells 9,200 Shares of Legend Biotech Co. (NASDAQ:LEGN)Skandinaviska Enskilda Banken AB publ lessened its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 74.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,100 shares oMarch 19, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Trims Position in Legend Biotech Co. (NASDAQ:LEGN)Zurcher Kantonalbank Zurich Cantonalbank decreased its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 18.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 40,913 shares of the company's stock after selling 9,355 shares during thMarch 19, 2025 | marketbeat.comBank of New York Mellon Corp Grows Stake in Legend Biotech Co. (NASDAQ:LEGN)Bank of New York Mellon Corp increased its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 12.5% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 131,416 shares of the company's stock after buying an additional 14,588 sMarch 19, 2025 | marketbeat.comMorgan Stanley Issues Pessimistic Forecast for Legend Biotech (NASDAQ:LEGN) Stock PriceMorgan Stanley reduced their target price on shares of Legend Biotech from $82.00 to $80.00 and set an "overweight" rating for the company in a report on Monday.March 18, 2025 | marketbeat.comMorgan Stanley Sticks to Their Buy Rating for Legend Biotech (LEGN)March 17, 2025 | markets.businessinsider.comLegend Biotech price target lowered to $80 from $82 at Morgan StanleyMarch 17, 2025 | markets.businessinsider.comHC Wainwright Boosts Earnings Estimates for Legend BiotechLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Analysts at HC Wainwright lifted their Q1 2025 earnings per share estimates for Legend Biotech in a research note issued on Wednesday, March 12th. HC Wainwright analyst M. Kapoor now expects that the company will post earnings per share of ($0.18)March 17, 2025 | marketbeat.comWilliam Blair Reduces Earnings Estimates for Legend BiotechLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Investment analysts at William Blair cut their Q1 2025 earnings per share (EPS) estimates for Legend Biotech in a research note issued on Wednesday, March 12th. William Blair analyst S. Corwin now forecasts that the company will post earnings per sMarch 17, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Stock Price Down 1.8% - Here's What HappenedLegend Biotech (NASDAQ:LEGN) Stock Price Down 1.8% - Should You Sell?March 15, 2025 | marketbeat.comQ4 EPS Estimates for Legend Biotech Lowered by HC WainwrightLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Analysts at HC Wainwright lowered their Q4 2025 earnings per share estimates for Legend Biotech in a note issued to investors on Wednesday, March 12th. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings per share of $March 15, 2025 | marketbeat.comLegend Biotech Reports $963 Million in CARVYKTI® Sales for 2024 and Initiates Commercial Production at Novartis FacilityMarch 13, 2025 | nasdaq.comLegend Biotech (LEGN) Gets a Buy from BarclaysMarch 13, 2025 | markets.businessinsider.comLegend Biotech's (LEGN) "Neutral" Rating Reiterated at GuggenheimGuggenheim reaffirmed a "neutral" rating on shares of Legend Biotech in a research note on Wednesday.March 13, 2025 | marketbeat.com Remove Ads Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address LEGN Media Mentions By Week LEGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LEGN News Sentiment▼1.250.86▲Average Medical News Sentiment LEGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LEGN Articles This Week▼156▲LEGN Articles Average Week Remove Ads Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ONC News BNTX News TEVA News ITCI News SMMT News GMAB News RDY News MRNA News VTRS News QGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LEGN) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LEGN Stock Free LEGN Stock Alerts